A study from researchers at the University of New Mexico has found that more than nine out of 10 migraine patients reported that inhaled cannabis provided relief for their symptoms.
To conduct the study, researchers tracked the effects of inhaled herbal cannabis on the symptoms experienced by 699 migraine sufferers over a period of 32 months.
Participants self administered cannabis while at home and reported their use and its effect on symptoms via the smartphone application Relief.
The study found that 94% of participants reported relief of symptoms within two hours of cannabis inhalation.
“These results suggest that whole dried Cannabis flower may be an effective medication for treatment of migraine- and headache-related pain, but the effectiveness differs according to characteristics of the Cannabis plant, the combustion methods, and the age and gender of the patient,” the researchers concluded.
Research Reveals More Evidence Of The Entourage Effect Researcher Jegason Diviant, who worked on the migraine study as well as another one that used the Releaf app to track the effect of cannabis on depression, reported that many patients are experiencing better results with whole cannabis flower than those reported with refined cannabinoid formulations.
“Phytocannabinoid isolates, such as THC or CBD, are less effective treatment options than whole-spectrum cannabis products. However, it is not enough to simply educate the public that whole-spectrum cannabis is superior to cannabis-derived isolates. There are thousands of cannabis strains, also known as chemotypes or chemovars, and they
all have a unique phytocannabinoid and terpene profile.” The researcher noted the wide range of effects that different varieties of cannabis can provide and urged a change in federal cannabis policy to spur more study.